Latest Weight-Loss Drug Faces Shortages [Video]

Latest Weight-Loss Drug , Faces Shortages .

The United States Food and Drug Administration(FDA) says that high demand has left the latestweight-loss drug, Zepbound, in short supply.

‘Newsweek’ reports that the Eli Lilly productis expected to experience limited availabilitythrough Q2 of 2024 as surging demand hasoutpaced the manufacturer’s expectations.

We have experiencedan unparalleled surge indemand for our type 2diabetes and obesity medicines, Eli Lilly spokesperson, via ‘Newsweek’.

We recognize this situation maycause a disruption in peoples’treatment regimens and areworking with purpose andurgency to help meetthe surge in demand, Eli Lilly spokesperson, via ‘Newsweek’.

The FDA said that Novo Nordisk’s weight-lossdrug, Wegovy, is also experiencing awidespread supply shortage with no endin sight for the drug’s limited availability.

By the year 2030, ‘Newsweek’ reportsthat the weight-loss drug market isexpected to grow to about $100 billion.

We expect our investments in manufacturing …